Horizon Bancorp Inc /In/ Vertex Pharmaceuticals Inc Transaction History

Horizon Bancorp Inc /In/

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$314.42 - $351.91 $7,546 - $8,445	-24 Reduced 55.81%	19 $7,000
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $6,514 - $7,431	-23 Reduced 34.85%	43 $14,000
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $158,882 - $178,742	-556 Reduced 89.39%	66 $19,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $7,669 - $9,093	-30 Reduced 4.6%	622 $169,000
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $55,242 - $72,471	-245 Reduced 27.31%	652 $189,000
Q1 2020 Apr 20, 2020	SELL	$199.77 - $247.81 $52,939 - $65,669	-265 Reduced 22.81%	897 $213,000
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $193,717 - $260,183	1,162 New	1,162 $254,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.